Advertisement

Marijuana use and its effects in pregnancy

      Background

      It is generally assumed that marijuana is one of the more widely used controlled substances during pregnancy. However, there remains a general paucity of population-based data regarding its use and subsequent perinatal morbidity. We hypothesized that direct patient query during pregnancy regarding marijuana, tobacco, and nicotine use would provide crucial initial population-based data on perinatal risk.

      Objective

      Our study sought to examine maternal and neonatal outcomes in pregnancies with reported marijuana exposure, in isolation or in combination with maternal cigarette smoking.

      Study Design

      We applied a retrospective cohort study design to subjects (n = 12,069) with available information on marijuana use and pregnancy outcomes. Since 2011, we have routinely and directly questioned all gravidae regarding use of marijuana, tobacco, and nicotine-containing products. We examined perinatal outcomes in marijuana smokers vs nonsmokers, as well as patients reporting both marijuana and cigarette smoking. Multivariate analysis enabled determination of adjusted odds ratios for maternal and fetal outcomes, adjusting for confounders. Significance was determined with Mann-Whitney U, χ2, and Fischer exact tests (as appropriate).

      Results

      In all, 106/12,069 reported marijuana use (0.88%), with 48/12,069 (0.4%; or 48/106, 45%) concurrently using cigarettes and marijuana. After controlling for potential confounding variables, while marijuana use alone was not associated with significant adverse outcomes, use in combination with cigarette smoking was significantly associated with increased risk of multiple adverse perinatal outcomes (increased occurrence of maternal asthma [adjusted odds ratio, 2.4; 95% confidence interval, 1.0–5.9]; preterm birth [adjusted odds ratio, 2.6; 95% confidence interval, 1.3–4.9]; decreased [<25th percentile] head circumference [adjusted odds ratio, 2.8; 95% confidence interval, 1.3–4.3]; and decreased [<25th percentile] birthweight [adjusted odds ratio, 2.8; 95% confidence interval, 1.6–5.0]). Maternal pregnancy-related hypertension was not increased in marijuana smokers (adjusted odds ratio, 1.30; 95% confidence interval, 0.681–2.498), or in cigarette smokers (adjusted odds ratio, 1.4; 95%, confidence interval, 0.9–1.9). However, co-users had elevated rates of preeclampsia compared to nonusers (adjusted odds ratio, 2.5; 95% confidence interval, 1.4–5.0).

      Conclusion

      In our initial cohort analysis, after controlling for potential confounders, while marijuana exposure alone was not associated with significant perinatal adverse outcomes, co-use with cigarette smoking rendered increased risk over either alone. Due to observed prevalence of concurrent cigarette and marijuana use, it is of likely importance to counsel patients regarding use in pregnancy.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hayatbakhsh M.R.
        • Flenady V.J.
        • Gibbons K.S.
        • et al.
        Birth outcomes associated with cannabis use before and during pregnancy.
        Pediatr Res. 2012; 71: 215-219
        • Mark K.
        • Desai A.
        • Terplan M.
        Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes.
        Arch Womens Ment Health. 2016; 19: 105-111
        • Warshak C.
        • Regan J.
        • Moore B.
        • Magner K.
        • Kritzer S.
        • Van Hook J.
        Association between marijuana use and adverse obstetrical and neonatal outcomes.
        J Perinatol. 2015; 35: 991-995
        • Linn S.
        • Schoenbaum S.C.
        • Monson R.R.
        • Rosner R.
        • Stubblefield P.C.
        • Ryan K.J.
        The association of marijuana use with outcome of pregnancy.
        Am J Public Health. 1983; 73: 1161-1164
        • Shiono P.H.
        • Klebanoff M.A.
        • Nugent R.P.
        • et al.
        The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study.
        Am J Obstet Gynecol. 1995; 172: 19-27
        • Chasnoff I.
        • Landress H.
        • Barrett M.
        The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida.
        N Engl J Med. 1990; 322: 1202-1206
        • Skolnick A.
        Drug screening in prenatal care demands objective medical criteria, support services.
        JAMA. 1990; 264: 309-310
        • Wilkinson S.T.
        • Yarnell S.
        • Radhakrishnan R.
        • Ball S.A.
        • D'Souza D.C.
        Marijuana legalization: impact on physicians and public health.
        Annu Rev Med. 2016; 67: 453-466
        • El Marroun H.
        • Tiemeier H.
        • Steegers E.A.
        • et al.
        Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study.
        J Am Acad Child Adolesc Psychiatry. 2009; 48: 1173-1181
        • Rabin R.A.
        • George T.P.
        A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use.
        Am J Addict. 2015; 24: 105-116
        • Suter M.A.
        • Anders A.M.
        • Aagaard K.M.
        Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming.
        Mol Hum Reprod. 2013; 19: 1-6
        • Suter M.A.
        • Aagaard K.
        What changes in DNA methylation take place in individuals exposed to maternal smoking in utero?.
        Epigenomics. 2012; 4: 115-118
        • Suter M.A.
        • Abramovici A.R.
        • Griffin E.
        • et al.
        In utero nicotine exposure epigenetically alters fetal chromatin structure and differentially regulates transcription of the glucocorticoid receptor in a rat model.
        Birth Defects Res Part A Clin Mol Teratol. 2015; 103: 583-588
        • Hutchings D.E.
        • Martin B.R.
        • Gamagaris Z.
        • Miller N.
        • Fico T.
        Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats.
        Life Sci. 1989; 44: 697-701
        • Cristino L.
        • Di Marzo V.
        Fetal cannabinoid receptors and the “dis-joint-ed” brain.
        EMBO J. 2014; 33: 665-667
        • Gray T.R.
        • Eiden R.D.
        • Leonard K.E.
        • Connors G.J.
        • Shisler S.
        • Huestis M.A.
        Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.
        Clin Chem. 2010; 56: 1442-1450
        • Hingson R.
        • Alpert J.J.
        • Day N.
        • et al.
        Effects of maternal drinking and marijuana use on fetal growth and development.
        Pediatrics. 1982; 70: 539-546
        • English D.R.
        • Hulse G.K.
        • Milne E.
        • Holman C.D.
        • Bower C.I.
        Maternal cannabis use and birth weight: a meta-analysis.
        Addiction. 1997; 92: 1553-1560
        • Fergusson D.M.
        • Horwood L.J.
        • Northstone K.
        Maternal use of cannabis and pregnancy outcome.
        BJOG. 2002; 109: 21-27
        • Fried P.A.
        • Watkinson B.
        • Willan Ottawa A.
        Marijuana use during pregnancy and decreased length of gestation.
        Am J Obstet Gynecol. 1984; 150: 23-27
        • Sonon K.E.
        • Richardson G.A.
        • Cornelius J.R.
        • Kim K.H.
        • Day N.L.
        Prenatal marijuana exposure predicts marijuana use in young adulthood.
        Neurotoxicol Teratol. 2015; 47: 10-15
        • Day N.L.
        • Goldschmidt L.
        • Thomas C.A.
        Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14.
        Addiction. 2006; 101: 1313-1322
        • Chandler L.S.
        • Richardson G.A.
        • Gallagher J.D.
        • Day N.L.
        Prenatal exposure to alcohol and marijuana: effects on motor development of preschool children.
        Alcohol Clin Exp Res. 1996; 20: 455-461
        • Conde-Agudelo A.
        • Althabe F.
        • Belizan J.M.
        • Kafury-Goeta A.C.
        Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review.
        Am J Obstet Gynecol. 1999; 181: 1026-1035
        • Wei J.
        • Liu C.X.
        • Gong T.T.
        • Wu Q.J.
        • Wu L.
        Cigarette smoking during pregnancy and preeclampsia risk: a systematic review and meta-analysis of prospective studies.
        Oncotarget. 2015; 6: 43667-43678
        • Kahr M.K.
        • Suter M.A.
        • Ballas J.
        • et al.
        Preterm birth and its associations with residence and ambient vehicular traffic exposure.
        Am J Obstet Gynecol. 2016; 215: 111.e1-111.e10
        • Aagaard K.
        • Ma J.
        • Antony K.M.
        • Ganu R.
        • Petrosino J.
        • Versalovic J.
        The placenta harbors a unique microbiome.
        Sci Transl Med. 2014; 6: 237ra65
        • Kahr M.K.
        • Suter M.A.
        • Ballas J.
        • et al.
        Geospatial analysis of food environment demonstrates associations with gestational diabetes.
        Am J Obstet Gynecol. 2016; 214: 110.e1-110.e9
        • ACOG
        Scope of services for uncomplicated obstetric care. Committee opinion no. 175.
        Int J Gynecol Obstet. 1996; 55: 96920
        • Keyes K.M.
        • Vo T.
        • Wall M.M.
        • et al.
        Racial/ethnic differences in use of alcohol, tobacco, and marijuana: is there a cross-over from adolescence to adulthood?.
        Soc Sci Med. 2015; 124: 132-141
        • Martin C.E.
        • Longinaker N.
        • Mark K.
        • Chisolm M.S.
        • Terplan M.
        Recent trends in treatment admissions for marijuana use during pregnancy.
        J Addict Med. 2015; 9: 99-104
        • Sartor C.E.
        • Agrawal A.
        • Lynskey M.T.
        • et al.
        Cannabis or alcohol first? Differences by ethnicity and in risk for rapid progression to cannabis-related problems in women.
        Psychol Med. 2013; 43: 813-823
        • Copersino M.L.
        • Boyd S.J.
        • Tashkin D.P.
        • et al.
        Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal.
        Am J Drug Alcohol Abus. 2010; 36: 311-319
        • Compton W.M.
        • Grant B.F.
        • Colliver J.D.
        • Glantz M.D.
        • Stinson F.S.
        Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002.
        JAMA. 2004; 291: 2114-2121
        • Hasin D.S.
        • Saha T.D.
        • Kerridge B.T.
        • et al.
        Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.
        JAMA Psychiatry. 2015; 291: 1-9
        • Stinson F.S.
        • Ruan W.J.
        • Pickering R.
        • Grant B.F.
        Cannabis use disorders in the USA: prevalence, correlates and co-morbidity.
        Psychol Med. 2006; 36: 1447-1460
        • Lindenberg C.S.
        • Strickland O.
        • Solorzano R.
        • Galvis C.
        • Dreher M.D.V.
        Correlates of alcohol and drug use among low-income Hispanic immigrant childbearing women living in the USA.
        Int J Nurs Stud. 1999; 36: 3-11
        • Berenson A.B.
        • Stiglich N.J.
        • Wilkinson G.S.
        • Anderson G.D.
        Drug abuse and other risk factors for physical abuse in pregnancy among white non-Hispanic, black, and Hispanic women.
        Am J Obstet Gynecol. 1991; 164: 1491-1499
        • Brown H.L.
        • Graves C.R.
        Smoking and marijuana use in pregnancy.
        Clin Obstet Gynecol. 2013; 56: 107-113
        • Emery R.L.
        • Gregory M.P.
        • Grace J.L.
        • Levine M.D.
        Addictive behaviors prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers.
        Addict Behav. 2016; 54: 52-58
        • Abouzeid M.
        • Versace V.L.
        • Janus E.D.
        • et al.
        Socio-cultural disparities in GDM burden differ by maternal age at first delivery.
        PLoS One. 2015; 10: 1-11
        • Aagaard-Tillery K.
        • Spong C.
        • Thom E.
        • et al.
        Pharmacogenomics of maternal tobacco use: metabolic gene polymorphisms and risk of adverse pregnancy outcomes.
        Obstet Gynecol. 2010; 115: 568-577
        • Aagaard-Tillery K.
        • Porter T.
        • Lane R.
        • Varner M.
        • Lacoursiere D.
        In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth.
        Am J Obstet Gynecol. 2008; 198: 66.e1-66.e6
        • Chang J.J.
        • Strauss J.F.
        • Deshazo J.P.
        • Rigby F.B.
        • Chelmow D.P.
        • Macones G.A.
        Reassessing the impact of smoking on preeclampsia/eclampsia: are there age and racial differences?.
        PLoS One. 2014; 9: e106446
        • Troxel W.M.
        • Ewing B.
        • D’Amico E.J.
        Adolescent sleep and alcohol or marijuana use.
        Sleep Heal. 2015; 1: 104-108